Public-private information exchange
To put in place systems for appropriate interaction between national governments, multilateral agencies, and manufacturers at national, regional and international levels.
Vaccine safety issues are the responsibility of those who provide the vaccines as well as those who develop or manufacture the products.
The importance of close collaboration between regulators and industry is well recognized in vaccine pharmacovigilance activities but may not occur in all situations. Manufacturers need information about adverse events from the national authorities, and national regulators need up-to-date safety information from manufacturers too.
The Global Vaccine Safety Initiative (GVSI) aims to promote a more efficient and rapid collection and exchange of information about vaccine safety issues between national regulatory authorities, vaccine manufacturers and multilateral agencies. The GVSI is developing a forum for information exchange between industry and other stakeholders, as well as a “think-tank” that will develop and propose new approaches in the field.
A globally harmonized mechanism for the collection and exchange of information on AEFI
Page last reviewed - 15 April 2014.